miRagen Therapeutics, Inc. forms alliance with Santaris Pharma
Santaris Pharma A/S and miRagen Therapeutics, Inc. Form Strategic Alliance to Develop microRNA-targeted Medicines for...
Search for Articles
Jun 23, 2010
Jun 1, 2010
CardiAQ Valve Technologies moves to new headquarters in Irvine, CA
CardiAQ Valve Technologies (“CVT”) completes move of its headquarters to a specialized facility in Irvine,...
May 20, 2010
CardiAQ Valve Technologies presents at EuroPCR 2010
CardiAQ Valve Technologies (“CVT”) to disclose data during “EuroPCR 2010” about the world’s first successful...
Jan 12, 2010
CardiAQ Valve Technologies closes $6.5M Series A
Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming...
Jun 9, 2009
miRagen Therapeutics, Inc. extends Series A to $12M
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA...
May 13, 2009
CardiAQ Valve Technologies receives seed funding from Broadview Ventures
CardiAQ Valve Technologies (CVT) received $750,000 in seed or ‘translational’ funding from Broadview Ventures Inc.—a...